The Valley Desk

ArticleCancer cellPublished

FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Cancer cell
Published
Subject terms
Cell Line, Tumor; Animals; Humans; Mice; Melanoma; Proto-Oncogene Proteins B-raf; Antineoplastic Combined Chemotherapy Protocols; Protein Kinase Inhibitors; Immunotherapy; Xenograft Model Antitumor Assays; Apoptosis; MAP Kinase Signaling System
PubMed ID
40020669
PubMed Central ID
PMC11903146
Added to directory
Source checked

Report a correction or request removal